FDA Enforcement
Class II
Ongoing
Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of RNA from SARSCoV-2 Catalog Number: 410700
Recall: Z-1008-2023
·
Reported February 1, 2023
Enforcement
- Recall Number
- Z-1008-2023
- Event ID
- 91356
- Classification
- Class II
- Status
- Ongoing
- Product Type
- Devices
- Firm
- Meridian Bioscience Inc
- Voluntary / Mandated
- Voluntary: Firm initiated
- Initial Notification
- Report Date
- February 1, 2023
- Initiation Date
- December 15, 2022
- Classification Date
- January 20, 2023
- Address
- 3471 River Hills Dr, N/A, Cincinnati, OH, 45244-3023, United States
Description
Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of RNA from SARSCoV-2 Catalog Number: 410700
Reason
Leakage of the original specimen from the plastic microfluidic cartridge (PIE), possibility that laboratory personnel may be exposed to aerosolized specimen containing SARS-CoV-2
Code Info
UDI: N/A Lot Numbers 410700P019, 410700P020, 410700P021, 410700P022, 410700P023, 410700P024, 410700P027
Distribution
US Nationwide distribution in the states of AZ, CA, IN, KS, KY, LA, MI, MN, NC, NY, OR, TX.
Quantity
92 kits